EUVIMEDEUVIMED entdecken
Open Access

GTF2I dosage regulates neuronal differentiation and social behavior in 7q11.23 neurodevelopmental disorders

Alejandro López-Tobón iD, Reinald Shyti iD, Carlo Emanuele Villa iD, Cristina Cheroni iD, Patricio Fuentes-Bravo iD, Sebastiano Trattaro iD, Nicolò Caporale iD, Flavia Troglio iD, Erika Tenderini iD, Marija Mihailovich iD, Adrianos Skaros iD, William T Gibson iD und 6 weitere

Science Advances · 2023

DOI: 10.1126/sciadv.adh2726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Alejandro López-Tobón und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Transcription Factors, TFIII, Transcription Factors, TFII. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Copy number variations at 7q11.23 cause neurodevelopmental disorders with shared and opposite manifestations. Deletion causes Williams-Beuren syndrome featuring hypersociability, while duplication causes 7q11.23 microduplication syndrome (7Dup), frequently exhibiting autism spectrum disorder (ASD). Converging evidence indicates GTF2I as key mediator of the cognitive-behavioral phenotypes, yet its role in cortical development and behavioral hallmarks remains largely unknown. We integrated proteomic and transcriptomic profiling of patient-derived cortical organoids, including longitudinally at single-cell resolution, to dissect 7q11.23 dosage–dependent and GTF2I -specific disease mechanisms. We observed dosage-dependent impaired dynamics of neural progenitor proliferation, transcriptional imbalances, and highly specific alterations in neuronal output, leading to precocious excitatory neuron production in 7Dup, which was rescued by restoring physiological GTF2I levels. Transgenic mice with Gtf2i duplication recapitulated progenitor proliferation and neuronal differentiation defects alongside ASD-like behaviors. Consistently, inhibition of lysine demethylase 1 (LSD1), a GTF2I effector, was sufficient to rescue ASD-like phenotypes in transgenic mice, establishing GTF2I -LSD1 axis as a molecular pathway amenable to therapeutic intervention in ASD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autism Spectrum DisorderTranscription Factors, TFIIITranscription Factors, TFIIMiceAnimalsHumansDNA Copy Number VariationsProteomicsSocial BehaviorPhenotypeMice, TransgenicCell DifferentiationHistone Demethylases

Substanzen

Histone DemethylasesTranscription Factors, TFIIIGTF2I protein, humanTranscription Factors, TFIIGtf2i protein, mouse

Autor:innen und Institutionen

  • Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy.
  • Human Technopole, Viale Rita Levi-Montalcini 1, 20157 Milan, Italy.
  • Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
  • Experimental Therapeutics Program, FIRC Institute of Molecular Oncology Foundation (IFOM), 20139 Milan, Italy.
  • Department of Medicine, University of Toronto, Toronto, ON, Canada.

ORCID-Profile: Alejandro López-Tobón, Reinald Shyti, Carlo Emanuele Villa, Cristina Cheroni, Patricio Fuentes-Bravo, Sebastiano Trattaro, Nicolò Caporale, Flavia Troglio, Erika Tenderini, Marija Mihailovich, Adrianos Skaros, William T Gibson, Alessandro Cuomo, Tiziana Bonaldi, Ciro Mercurio, Mario Varasi, Lucy Osborne, Giuseppe Testa

Zitieren

APA

López-Tobón, A., Shyti, R., Villa, C. E., Cheroni, C., Fuentes-Bravo, P., Trattaro, S., Caporale, N., Troglio, F., Tenderini, E., Mihailovich, M., Skaros, A., Gibson, W. T., Cuomo, A., Bonaldi, T., Mercurio, C., Varasi, M., Osborne, L., & Testa, G. (2023). GTF2I dosage regulates neuronal differentiation and social behavior in 7q11.23 neurodevelopmental disorders. Science Advances. https://doi.org/10.1126/sciadv.adh2726

Vancouver

López-Tobón A, Shyti R, Villa CE, Cheroni C, Fuentes-Bravo P, Trattaro S, et al. GTF2I dosage regulates neuronal differentiation and social behavior in 7q11.23 neurodevelopmental disorders. Science Advances. 2023. doi:10.1126/sciadv.adh2726

BibTeX
@article{LpezTobn2023,
  author = {López-Tobón, Alejandro and Shyti, Reinald and Villa, Carlo Emanuele and Cheroni, Cristina and Fuentes-Bravo, Patricio and Trattaro, Sebastiano and Caporale, Nicolò and Troglio, Flavia and Tenderini, Erika and Mihailovich, Marija and Skaros, Adrianos and Gibson, William T and Cuomo, Alessandro and Bonaldi, Tiziana and Mercurio, Ciro and Varasi, Mario and Osborne, Lucy and Testa, Giuseppe},
  title = {GTF2I dosage regulates neuronal differentiation and social behavior in 7q11.23 neurodevelopmental disorders},
  journal = {Science Advances},
  year = {2023},
  doi = {10.1126/sciadv.adh2726}
}
Kostenlos starten →